Literature DB >> 7040418

Control of growth and normal differentiation in leukemic cells: regulation of the developmental program and restoration of the normal phenotype in myeloid leukemia.

L Sachs.   

Abstract

The origin and evolution of malignancy involves a sequence of genetic changes. Evidence has, however, been obtained with various types of tumors that malignant cells have not lost the genes that control normal growth and differentiation. An in vitro cloning and cell culture system has been developed to determine and dissect the controls that regulate normal myeloid cell growth, differentiation, and malignancy and to suggest a new approach to the therapy of myeloid leukemia based on the induction of normal differentiation in malignant cells. Experiments on induction of normal cell differentiation and restoration of the normal phenotype in myeloid leukemia by the physiological inducer of differentiation, the appropriate molecular form of the macrophage and granulocyte-inducing protein MGI, have also been used to formulate a general model for regulation of developmental programs and the origin and evolution of the malignancy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7040418     DOI: 10.1002/jcp.1041130423

Source DB:  PubMed          Journal:  J Cell Physiol Suppl        ISSN: 0737-1462


  11 in total

1.  Colony stimulating factor-induced differentiation of murine M1 myeloid leukemia cells is permissive in early G1 phase.

Authors:  H Tsuda; L M Neckers; D H Pluznik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

2.  Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs).

Authors:  Ja Hye Myung; Cari A Launiere; David T Eddington; Seungpyo Hong
Journal:  Langmuir       Date:  2010-06-01       Impact factor: 3.882

3.  Some properties of Bomirski Ab amelanotic melanoma cells, which underwent spontaneous melanization in primary cell culture. Growth kinetics, cell morphology, melanin content and tumorigenicity.

Authors:  A Słomiński
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

4.  Dimethyl sulfoxide-induced differentiation does not alter tumorigenicity of neuroblastoma cells.

Authors:  Y L Danon; E Kaminsky
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

Review 5.  Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.

Authors:  A Jacobs
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

6.  Cell differentiation and malignancy.

Authors:  L Sachs
Journal:  Cell Biophys       Date:  1986-12

Review 7.  Human preleukaemia: do we have a model?

Authors:  A Jacobs
Journal:  Br J Cancer       Date:  1987-01       Impact factor: 7.640

8.  Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF).

Authors:  D P Gearing; N M Gough; J A King; D J Hilton; N A Nicola; R J Simpson; E C Nice; A Kelso; D Metcalf
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

9.  Autoinduction of differentiation in myeloid leukemic cells: restoration of normal coupling between growth and differentiation in leukemic cells that constitutively produce their own growth-inducing protein.

Authors:  G Symonds; L Sachs
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

10.  Purification and characterization of human granulocyte colony-stimulating factor (G-CSF).

Authors:  H Nomura; I Imazeki; M Oheda; N Kubota; M Tamura; M Ono; Y Ueyama; S Asano
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.